eISSN: 2083-8441
ISSN: 2081-237X
Pediatric Endocrinology Diabetes and Metabolism
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Suplementy Rada naukowa Recenzenci Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac
SCImago Journal & Country Rank


 
1/2021
vol. 27
 
Poleć ten artykuł:
Udostępnij:
więcej
 
 
Opis przypadku

Rzadki przypadek 15-letniej pacjentki z kariotypem 46,XY, pierwotnym brakiem miesiączki i prawidłowym rozwojem piersi

Małgorzata Morawiecka-Pietrzak
1
,
Ewelina Dąbrowska
2
,
Aleksandra Gliwińska
3
,
Anna Góra
2
,
Gabriela Geisler
2
,
Aneta Gawlik
4
,
Grzegorz Kudela
5
,
Katarzyna Ziora
2

1.
Department of Pediatrics, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
2.
Department of Medical and Molecular Biology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
3.
Paediatric Nephrology Ward with Dialysis Division for Children, Public Clinical Hospital No. 1 in Zabrze, Poland
4.
Department of Paediatrics and Paediatric Endocrinology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland
5.
Department of Paediatric Surgery and Urology, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland
Pediatr Endocrinol Diabetes Metab 2021; 27 (1): 62–67
Data publikacji online: 2020/12/17
Plik artykułu:
- A rare case.pdf  [0.44 MB]
Pobierz cytowanie
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
 

Introduction

A disorder of sex development (DSD) is defined as a congenital condition in which development of chromosomal, gonadal, or anatomical sex is atypical [1–3]. According to the Chicago classification, DSD is subdivided into three groups on the basis of cytogenic, hormonal, gonadal histology, and clinical findings: 46,XY (primary disorder of testicular development or disorders in androgen synthesis or action), 46,XX (disorders of ovarian development, congenital adrenal hyperplasia, aromatase deficiency), and sex chromosome disorders (Klinefelter syndrome, Turner syndrome, chimerism, mixed gonadal dysgenesis) [1, 3, 4]. The overall rate of incidence is estimated at 1 : 4500 births, and that of DSD with Y chromosome material is approximately 1 : 20,000 births [4]. In patients with DSD the rate of associated congenital anomalies is significantly higher than in the general population. These abnormalities include small for gestational age, congenital cardiovascular diseases, and central nervous system disorders [1]. Swyer syndrome is an example of 46,XY DSD with a female phenotype. It is a rare condition with an incidence rate estimated at 1:80,000 births [1, 5, 6]. Patients have normal to tall stature, bilateral dysgenetic gonads, and the presence of müllerian structures. Pubertal development is delayed. The most common symptom that encourages patients with Swyer syndrome to consult a physician is primary amenorrhoea. This disorder is defined as either a lack of menarche by 14 years of age in the absence of secondary sexual characteristics or lack of menses by 15 years of age in the presence of normal growth and secondary sexual characteristics [7–9]. Approximately 2.5% of adolescents experiencing primary amenorrhoea suffer from Swyer syndrome [7]. It must be kept in mind that in every case of DSD with Y chromosome and female phenotype, there is an increased risk of gonadal germ cell tumours, compared with the general population [4, 5]. Gonadal neoplasms occur in 15-55% of complete gonadal dysgenesis patients [10, 11]. The current evidence strongly recommends prophylactic gonadectomy in patients with 46,XY DSD at the time of diagnosis.

Case report

A 15-year-old girl was admitted to the Department of Child Endocrinology due to primary amenorrhoea. The girl’s medical history included birth from the first pregnancy, by vaginal delivery at 40 weeks of gestation with a birth weight of 3920 g, body length of 60 cm, and Apgar score of 10 at five minutes. The child’s psychomotor development was normal. Until admission she did not require hospitalisation or specialist treatment. A growth spurt had been observed about 1.5–2 years before admission. Breast enlargement had been noted a year before admission. The family history was irrelevant. The girl’s mother experienced menarche at 15 years of age. Upon admission to the Department of Child Endocrinology the patient was in good general condition. In the physical examination obesity (the body weight of 89 kg [> 97c] and the height of 171.4 cm [> 97c], body mass index [BMI] = 30.3 kg/m2) and stretch marks on the thighs were noted. The development of breasts was of Tanner stage B4 and pubic hair of Tanner stage P4. No apparent abnormalities within external genitalia or other evidence of virilisation were observed. Laboratory findings revealed normal biochemistry. Hormonal tests were as follows: hypergonadotropic hypogonadism with low level of oestradiol and testosterone (follicle stimulating hormone 48.68 mIU/ml, luteinising hormone 25.79 mIU/ml, oestradiol 16.79 pg/ml [ranges shown in Table I], testosterone 14.21 ng/dl [normal range: 6-86 ng/dl]). Pelvic ultrasound revealed a uterus that showed modest oestrogenisation, which was, however, insufficient to make the endometrium visible. No ovaries were found. In the projection of a right gonad a solid structure with a vague ultrasound image was found. To verify the results of the ultrasound examination, magnetic resonance imaging was performed – the uterus dimensions were appropriate for the age (6.0 × 1.8 × 3.2 cm). In the left gonad projection, a small structure with vesicles up to 3 mm was visible. The right gonad was not visible, while a 7 mm thick tissue lesion was found in that area. Fallopian tubes were present. In the right lower abdomen, a structure of unknown origin and with dimensions of 22 × 14 × 15 mm was visible. In the course of further diagnostic tests, the chromosome analysis revealed a 46,XY karyotype, using a technique of analysing peripheral leukocytes (50 metaphase cells counted). Hormonal tests showed euthyreosis and morning hyperprolactinaemia with normal daily profile of prolactin. Chorionic gonadotropin subunit β and α-fetoprotein serum concentrations remained within normal limits (1.28 mIU/ml [normal range: 0–5 mIU/ml] and 1.51 IU/ml [normal range: 0–7 IU/ml], respectively). The bone age was assessed as 14-–15 years according to the Greulich & Pyle method. After completing a detailed assessment, the patient was qualified for a laparoscopic bilateral gonadectomy. Postoperative histopathological examination revealed gonadoblastoma within the right dysgenetic gonad and the foci of gonadoblastoma in the left gonad. No structures characteristic for ovarian or testicular tissue were found. The patient is currently under constant observation in an outpatient setting. The patient is currently receiving transdermal oestradiol replacement therapy to prevent hypoestrogenism and will begin administration of progesterone preparation. The patient was informed about vitamin D deficiency prevention and adequate calcium supplementation. The parents of the patient signed written informed consent for the publication of this case report.

Discussion

Complete gonadal dysgenesis (CGD) – Swyer syndrome – was described for the first time in 1955 by G. Swyer [11]. Characteristic features of this disorder are as follows: female phenotype, male karyotype, unambiguously female external genitalia, delayed puberty, and the presence of müllerian structures with streak gonads [1, 11]. The affected person usually has a tall stature, which may be caused by the effect of the Y chromosome or delayed epiphyseal closure due to the deficiency of sex steroids [1]. Generally, due to the absence of hormonal activity of ovaries, there is no appearance of breast development and menarche. Usually, this disorder is identified in adolescence, during the diagnosis of primary amenorrhoea and delay in pubertal signs [12].
The most relevant aspect of this article is the presence of breast development in a girl with Swyer syndrome, which could mask gonadal dysgenesis and delay the diagnosis. According to the best of our knowledge, spontaneous breast development in patients with 46,XY CGD was reported in isolated cases [6, 10, 13–17]). However, the breast development was not adequate in all the reports and did not achieve Tanner stage V, as in our patient. Catli et al. reported a case of a 46,XY CGD teenager with adequate breast development and irregular menstrual periods [6]. There has also been a case of Swyer syndrome reported with adequate development of secondary sexual features and secondary amenorrhoea [10]. Meyer et al. reported a case of a female with primary amenorrhoea, well developed breasts and one spontaneous vaginal bleeding event [17]. Usually, it is believed that the hormonal activity of tumours within the dysgenetic gonad is responsible for the stimulation of breast development. Fukamatsu et al. [18] reported a case of gonadoblastoma secreting male and female sex steroids. In such a case, virilisation is possible if mainly androgens are synthesised. However, when oestrogen synthesis dominates, female secondary sexual characteristics develop [18–21], although it should be kept in mind that breast development in patients with Swyer syndrome is not always evidence of gonadal malignancy [10, 15]. A case of CGD with spontaneous breast development despite low oestradiol level, clinical features of hypoestrogenaemia (i.a. osteoporosis) and no gonadal tumours were also described [15]. Hypotheses concerning the origin of oestrogens in girls who suffer from Swyer syndrome say that the production of female sex hormones is possible through the streak gonads. In such a case they can be a source of oestrogen and the reason for adequate breast development [6, 10, 15]. An overlap between non-mosaic Swyer syndrome with 46,XX/46,XY mosaicism is very rare. In this variant, more gonadal functions have been retained and patients are virilised [1]. Moreover, peripheral conversion of androgens to oestrogens and an increased sensitivity of breast tissue to oestrogens are also possible [6, 10, 15]. In such cases, allegedly correctly progressing puberty may delay the diagnosis. It seems that in the analysed case, the aforementioned mechanisms (production of oestrogens through the streak gonads, peripheral conversion of androgens, and an increased sensitivity of breast tissue to oestrogens) could have led to the breast development.
In physiological development, expression of the sex determining region Y (SRY) gene located on the Y chromosome, initiates a genetic cascade that causes the undifferentiated gonad to develop as a testis. In case of improper expression of this fragment, the testes do not develop and the Müllerian ducts persist to form the fallopian tubes, uterus, and upper third part of the vagina [1, 22]. Only in 10–20% of patients with Swyer syndrome was a mutation in SRY confirmed [1, 6, 10, 11]. Moreover, there are still new reports of new mutations inactivating SRY [11, 23]. In the remaining 80–90% of cases other mutations are probably responsible for the symptoms of gonadal dysgenesis. The reason for the occurrence of 46,XY DSD may be mutations in the following genes: SOX9, WT1 (Wilms’ tumour suppressor gene), SF1, DAX1, DHH, FGF9, DMRT1, M33, WNT4, FOXL2, RSPO1, LHX9, EMX2, LIM1, and others (e.g. MAP3K1 gain-of-function mutation) [2, 3, 22, 24]. However, in approximately 50% of the cases, the underlying genetic cause remains unknown [6]. A routine karyotype should be requested in all individuals experiencing primary amenorrhoea, who have been diagnosed with hypergonadotropic hypogonadism and/or ovarian tumour [1, 8]. If virilisation signs are observed and testosterone and its metabolites levels are elevated, a urinary steroid profile analysis should be considered [1].
In the case of 46, XY karyotype in a patient with primary amenorrhoea, Swyer’s syndrome, congenital adrenal hyperplasia (CAH) (from deficit of the 17α-hydroxylase/17–20 lyase enzyme), and complete androgen insensitivity syndrome (CAIS) should be considered in the differential diagnosis [17, 25]. Deficiency of 17α-hydroxylase/17–20 lyase is a rare form of CAH, caused by loss-of-function mutations in CYP17A1. It appears in adolescence or in adult life. XY children with this form of CAH develop female phenotype; however, they have a histologically normal testis. Due to the accumulation of mineralocorticoids, a characteristic symptom in these patients is difficult-to-treat hypertension [17, 26]. Patients with CAIS are phenotypically female with female gender identification. Gonads are found high in the inguinal canals or in the pelvis, and müllerian structures are absent. Hormonal tests usually show elevated oestrogen and androgen levels [5, 25]. The androgen insensitivity is caused by the androgen receptor mutations [2]. Table II shows the diagnostic tests in cases of primary amenorrhoea [26, 27]. Because of the possibility of neoplasm transformation in patients with 46,XY karyotype and dysgenetic gonads, bilateral gonadectomy should be performed as soon as the diagnosis is made [1, 4, 5, 7, 10, 19, 22, 28]. According to various authors, the occurrence of tumours in Swyer syndrome varies from 15% to as much as 55% of cases, with the incidence increasing with age [1, 4, 11, 20]. Among all DSD, in patients with 46,XY CGD the tumour presence and malignancy risk are the highest. Therefore, Swyer syndrome is considered the most threatening disorder [4]. The most common tumours include gonadoblastoma and dysgerminoma. Gonadoblastoma almost always develops in DSD with the presence of Y chromosome material, and more than 80% of cases involve patients with a female phenotype [20]. Gonadoblastoma is a tumour originating from persistent undifferentiated cells of a dysgenetic gonad. Its development is associated with the expression of the testis-specific protein, Y-linked gene (TSPY), and with the presence of SRY, SOX9, and WT-1 mutations [1]. Despite being a benign tumour, it may progress further and could be a precursor to malignant germ cell malignancy – usually dysgerminoma [1, 4, 19, 20, 28]. It is estimated that half of gonadoblastoma will have malignant transformation [5]. The tumour can be uni- or bilateral. There have also been reported cases of concomitant occurrence of gonadoblastoma and dysgerminoma within one gonad [11]. Diagnosis is made most often in the pubertal age. However, a case of a three-month-old child with mixed gonadal dysgenesis and concomitant gonadoblastoma has been described [28]. If gonadoblastoma is diagnosed, the prognosis is very good. However, if the features of malignant transformation are found, then the survival rate decreases [20]. Patients with CGD are always reared as female, according to the phenotypic sex, and are unlikely to have gender dysphoria [5, 12]. The case of the described patient was similar. However, psychological care is advisable [4]. Moreover, patients with 46,XY and gonadal dysgenesis require sex hormone treatment. It helps to induce and maintain adequate breast development and menstruation, and to achieve an optimal peak bone mass. For this purpose, oestrogen and progesterone supplementation is used until menopausal age [1]. Despite of the lack of female gonads, pregnancy is possible because these patients have normal müllerian structures; it is possible via ova donation and in vitro fertilisation. Because of the genetic background of Swyer syndrome, familial screening should be considered [11, 19].
In conclusion, phenotypic female 46,XY DSD is a rare disorder, diagnosed most often in adolescence. Our observation underlines the need to consider DSD 46,XY in the presence of primary amenorrhoea, even when pubertal development is present. Normal breast development may mask gonadal dysgenesis and delay diagnosis. It has to be kept in mind that germ cell tumours have a tendency to grow and metastasise rapidly. Delayed diagnosis may increase the risk of malignant transformation and cause a poor diagnosis and reduced survival rates. In the described case, genetic analysis did not reveal any of the known mutations connected with CGD. Despite that, prophylactic gonadectomy was performed due to the high risk of malignancy in every case of 46 XY with gonadal dysgenesis. Early sex hormone treatment helps to induce and maintain typical pubertal and psychosexual development, and to achieve an optimal peak bone mass.
1. King TFJ, Conway GS. Swyer syndrome. Curr Opin Endocrinol Diabetes Obes 2014; 21: 504–510. doi: 10.1097/MED.0000000000000113
2. Starzyk J. Zaburzenia różnicowania płci o typie odwrócenia płci jako przyczyna opóźnionego pokwitania u młodzieży. Pediatric Endocrinol 2003; 3: 37–46.
3. Hughes IA. Disorders of sex development: a new definition and classification. Best Pract Res Clin Endocrinol Metab 2008; 22: 119–134. doi: 10.1016/j.beem.2007.11.001
4. Huang H, Wang C, Tian Q. Gonadal tumour risk in 292 phenotypic female patients with disorders of sex development containing Y chromosome or Y-derived sequence. Clin Endocrinol (Oxf) 2017; 86: 621–627. doi: 10.1111/cen.13255.
5. Wong YS, Tam YH, Pang KKY, et al. Clinical heterogeneity in children with gonadal dysgenesis associated with non-mosaic 46,XY karyotype. J Pediatr Urol 2017; 13: 508.e1-508.e6. doi: 10.1016/j.jpurol.2017.03.021
6. Çatlı G, Alparslan C, Can PŞ, et al. An Unusual Presentation of 46,XY Pure Gonadal Dysgenesis: Spontaneous Breast Development and Menstruation. J Clin Res Pediatr Endocrinol 2015; 7: 159-162. doi: 10.4274/jcrpe.1919
7. Jabeen S, Raees M, Nisar M. Causes Of Primary Amenorrhea At Tertiary Level Hospital. J Ayub Med Coll Abbottabad 2018; 30: 60–63.
8. Kriplani A, Goyal M, Kachhawa G, et al. Etiology and management of primary amenorrhoea: A study of 102 cases at tertiary centre. Taiwan J Obstet Gynecol 2017; 56: 761–764. doi: 10.1016/j.tjog.2017.10.010
9. Eren E, Saglam H, Cakir ED, et al. Etiological evaluation of adolescents with primary amenorrhea. Indian J Pediatr 2014; 81: 861–865. doi: 10.1007/s12098-013-1266-6
10. Ilter E, Haliloglu B, Akin FT, et al. Pure 46,XY gonadal dysgenesis (Swyer syndrome) with breast development and secondary amenorrhea. Gynecol Obstet Invest. 2008; 66: 214–216. doi: 10.1159/000146086
11. Milewicz T, Mrozińska S, Szczepański W, et al. Dysgerminoma and gonadoblastoma in the course of Swyer syndrome. Polish J Pathol 2016; 67: 411–414. doi: 10.5114/pjp.2016.65876
12. Berberoğlu M, Şıklar Z. The evaluation of cases with Y-chromosome gonadal dysgenesis: Clinical experience over 18 years. J Clin Res Pediatr Endocrinol 2018; 10: 30–37. doi: 10.4274/jcrpe.4826
13. Dumic M, New MI, Lin-Su K, et al. Report of fertility in a woman with a predominantly 46,XY karyotype in a family with multiple disorders of sexual development. J Clin Endocrinol Metab 2008; 93: 182–189. doi: 10.1210/jc.2007-2155
14. Karimian N, Ghadakzadeh S, Eshraghi M. Swyer syndrome in a woman with pure 46,XY gonadal dysgenesis and a hypoplastic uterus: a rare presentation. Fertil Steril 2010; 93: 267.e13-267.e14. doi: 10.1016/j.fertnstert.2009.09.062
15. Tanwani LK, Chudgar D, Murphree SS, et al. A case of gonadal dysgenesis, breast development, Graves’ disease, and low bone mass. Endocr Pract 2003; 9: 220–224. doi: 10.4158/EP.9.3.220
16. Dural O, Evruke I, Can S, et al. Atypical Presentation of Swyer Syndrome. J Pediatr Adolesc Gynecol 2019; 32: 645–647. doi: 10.1016/j.jpag.2019.07.007
17. Meyer KF, Freitas Filho LG, Silva KI, et al. The XY female and SWYER syndrome. Urol Case Rep 2019; 26: 100939. doi:10.1016/j.eucr.2019.100939
18. Fukamatsu Y, Tsukahara Y, Hayashi S, et al. Bilateral gonadoblastoma producing steroid hormones in a patient with 45,X/46,XY gonadal dysgenesis. Gynecol Obstet Invest 1990; 30: 189–191. doi: 10.1159/000293266
19. Capito C, Leclair MD, Arnaud A, et al. 46,XY pure gonadal dysgenesis: clinical presentations and management of the tumor risk. J Pediatr Urol 2011; 7: 72–75. doi: 10.1016/j.jpurol.2010.01.010
20. Jorgensen EV, Steffensen T, Gilbert-Barness E, et al. Clinical pathologic correlation: primary amenorrhoea and bilateral adnexal tumors. Fetal Pediatr Pathol 2008; 27: 245–258. doi: 10.1080/15513810802447920
21. Zielińska D, Zajaczek S, Rzepka-Górska I. Tumors of dysgenetic gonads in Swyer syndrome. J Pediatr Surg 2007; 42: 1721–1724.
22. Mannaerts D, Muys J, Blaumeiser B, Jacquemyn Y. A rare cause of primary amenorrhoea, the XY female with gonadal dysgenesis. BMJ Case Rep 2015; 2015: bcr2014206609. doi: 10.1136/bcr-2014-206609
23. Paris F, Philibert P, Lumbroso S, et al. Primary amenorrhea in a 46,XY adolescent girl with partial gonadal dysgenesis: identification of a new SRY gene mutation. Fertil Steril 2007; 88: 1437.e21-1437.e25. doi: 10.1016/j.fertnstert.2007.01.048
24. Rocca MS, Ortolano R, Menabò S, et al. Mutational and functional studies on NR5A1 gene in 46,XY disorders of sex development: identification of six novel loss of function mutations. Fertil Steril 2018; 109: 1105–1113. doi: 10.1016/j.fertnstert.2018.02.123
25. Yao Y, He HJ, Han JS, Guo HY. Dysgerminoma and gonadoblastoma with para-aortic lymph node metastasis in a patient with swyer syndrome. Chin Med J (Engl) 2017; 130:1882–1883. doi: 10.4103/0366-6999.211548
26. Yoon JY, Cheon CK. Evaluation and management of amenorrhea related to congenital sex hormonal disorders. Ann Pediatr Endocrinol Metab 2019; 24: 149–157. doi: 10.6065/apem.2019.24.3.149
27. Klein DA, Paradise SL, Reeder RM. Amenorrhea: A systematic approach to diagnosis and management. Am Fam Physician 2019; 100: 39–48.
28. Cunha SC, de Andrade JGR, de Angelis CM, et al. Early development of a gonadal tumor in a patient with mixed gonadal dysgenesis. Arch Endocrinol Metab 2018; 62: 644–647. doi: 10.20945/2359-3997000000091
facebook linkedin twitter
© 2021 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe